Friday, July 31, 2026

How K-Bio is Set to Thrive Amid U.S. Regulation Changes for Biosimilars in 2027

Major countries are easing biosimilar regulations, boosting K-Bio opportunities and reducing development costs by up to 90%.

Paul Atkins Declares End of SEC’s Hostile Crypto Approach, Promises Clearer Rules

SEC Chair Gary Gensler announces a shift in regulatory approach for the digital asset industry, aiming to provide clear rules instead of restrictions.

Pentagon Weighs Buying Warships Built in South Korea and Japan Under New Navy Funding Plan

The U.S. Defense Department may use $1.85 billion for naval vessels from South Korea and Japan amid Congress budget debates.

Tag: Fenofibrate

PharmGen Science Releases Tabapheno Extended-Release for Dyslipidemia Treatment

PharmGen Science launches Tabapheno Extended-Release Tablets for mixed dyslipidemia, enhancing treatment convenience and adherence.

Top News

- Our Sponsors Ad -

Follow us